Analytical study and cytotoxicity test of azo dye in vitro

Authors

  • Hanan M. Ali Department of Chemistry, College of Education for pure Sciences, University of Basrah, Basrah, Iraq.
  • Baryham Saad Abdul Samad
  • Noha Loay Mohammed
  • Saad Shaheen Hammadi
  • Asawer Salim Temma

DOI:

https://doi.org/10.5281/zenodo.10246975

Abstract

Analytical study of the azo dye (HA) showed that it can be affected by their solubility and the dielectric constant (D) of solvents. The MTT assay was used to test the effectiveness of HA against MCF-7 cell line, which indicated their sensible inhibition rates in contrast with the control (C). The assay also showed the great ability of the (HA) azo dye in destroying the MDA-MB231 cells and how it affected their viability%, which was better than their ability against the MCF-7 cell line. And this activity increased with the increase of their concentration. Statistical analysis gave P<0.05. Furthermore, the liver tissues of designated mice were normal in contrast with control (C). Therefore, after seeing its effectiveness as shown in the study, we recommend the specified HA to be a novel drug, that contains two medicines, (levothyroxine and paracetamol) in their structure. The new drug can give three effects at the same time, represented on thyroid medication, pain relive and anti-cancer effect.

References

Al-Maliki, S. J. (2000). A behavioral and some physiological effect of (apum graveolens) seeds in albino mice. J Sci Bas, 18(2), 77–88.

Al-Shammari, A. M., Al-Esmaeel, W. N., Al Ali, A. A. A., Hassan, A. A., & Ahmed, A. A. (2019). Enhancement of oncolytic activity of Newcastle disease virus through combination with retinoic acid against digestive system malignancies. Molecular Therapy, 27(4), 126–127.

Al-Shammari, A. M., Alshami, M. A., Umran, M. A., Almukhtar, A. A., Yaseen, N. Y., Raad, K., & Hussien, A. A. (2015). Establishment and characterization of a receptor-negative, hormone-nonresponsive breast cancer cell line from an Iraqi patient. Breast Cancer: Targets and Therapy, 223–230.

Ali, H. M., Mohsin, R. H., & AlKinani, M. F. H. (2019). Anticancer Drugs as a Model for Destroying and Reducing the Growth of Human Breast MDA-MB231 Cancer Cells. Indian Journal of Public Health, 10(10), 2879.

Comşa, Ş., Cimpean, A. M., & Raica, M. (2015). The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Research, 35(6), 3147–3154.

Freshney, R. I. (2015). Culture of animal cells: a manual of basic technique and specialized applications. John Wiley & Sons.

Johnson, P., Challis, R., Chowdhury, F., Gao, Y., Harvey, M., Geldart, T., Kerr, P., Chan, C., Smith, A., & Steven, N. (2015). Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clinical Cancer Research, 21(6), 1321–1328.

Jóźwiak-Bebenista, M., & Nowak, J. Z. (2014). Paracetamol: mechanism of action, applications and safety concern. Acta Poloniae Pharmaceutica, 71(1), 11–23.

Loibl, S., Poortmans, P., Morrow, M., Denkert, C., & Curigliano, G. (2021). Epidemiology and risk factors. Breast Cancer. Lancet, 397, 1750–1769.

Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014). Cancer statistics, 2014. CA: A Cancer Journal for Clinicians, 64(1), 9–29.

Wu, C.-C., Yu, Y.-Y., Yang, H.-C., Nguyen, P. A., Poly, T. N., Islam, M. M., Iqbal, U., Khan, H. A. A., Wang, Y.-C., & Cheng, Y.-T. (2018). Levothyroxine use and the risk of breast cancer: A nation-wide population-based case–control study. Archives of Gynecology and Obstetrics, 298, 389–396.

Downloads

Published

2023-12-03

How to Cite

M. Ali, H., Saad Abdul Samad, B. ., Loay Mohammed, N. ., Shaheen Hammadi, S. ., & Salim Temma, A. (2023). Analytical study and cytotoxicity test of azo dye in vitro . Journal of Wildlife and Biodiversity, 7(Special Issue), 471–477. https://doi.org/10.5281/zenodo.10246975